Together, these findings suggest that in HNSCC overactive PI3K/mTOR activity may establish of an immunosuppressive microenvironment in addition to its best known function in growth promotion, and that these two cancer-driver processes can be concomitantly suppressed by HER3 blockade. Here, ERBB3 is linked to head and neck squamous cell carcinoma.